Journal of Physical Therapy and Sports Medicine

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Short Communication - Journal of Physical Therapy and Sports Medicine (2024) Volume 8, Issue 6

Neurological Disorders: Understanding the Impact on the Brain and Nervous System.

George Vesly*

Georgios Kakavas Department of Physical Therapy, University of Thessaly Volos, Greece

*Corresponding Author:
George Vesly
Georgios Kakavas Department of Physical Therapy,
University of Thessaly Volos,
Greece
E-mail:info@george.gr

Received: 02-Nov-2024, Manuscript No. AAJPTSM-24-155546; Editor assigned: 05-Nov-2024, PreQC No. AAJPTSM-24-155546;(PQ); Reviewed: 21-Nov-2024, QC No AAJPTSM-24-155546; Revised: 25-Nov-2024, QC No AAJPTSM-24-155546; Published: 30-Nov-2024, DOI:10.35841/aajptsm-8.6.232.

Citation:Vesly G. Neurological disorders: Understanding the impact on the brain and nervous system. J Phys Ther Sports Med. 2024; 8(6):232.

Visit for more related articles at Journal of Physical Therapy and Sports Medicine

Abstract

  

Introduction

Neurological disorders encompass a wide range of conditions that affect the brain, spinal cord, and peripheral nerves. These disorders can impact motor skills, cognition, emotions, and even autonomic functions, leading to varying degrees of disability and impairment. Some neurological disorders are congenital, while others develop due to injury, infection, or degenerative processes [1].

Understanding these conditions, their causes, symptoms, and treatment options is critical for managing their impact on individuals and improving quality of life. Alzheimer's disease is the most common form of dementia, a category of brain disorders that lead to a decline in cognitive functions like memory, reasoning, and problem-solving [2].

Alzheimer’s is characterized by the accumulation of amyloid plaques and tau tangles in the brain, which disrupt normal cell function. Symptoms include short-term memory loss, confusion, mood swings, and difficulty completing familiar tasks. Although the exact cause of Alzheimer’s is still unknown, age and genetic factors are major risk factors [3].

While there is no cure for Alzheimer’s, medications such as cholinesterase inhibitors and lifestyle modifications can help manage symptoms and slow progression. Parkinson’s disease is a progressive neurodegenerative disorder that primarily affects movement. It is caused by the death of dopamine-producing neurons in the brain, particularly in the substantia nigra, a region responsible for controlling voluntary movement [4].

Symptoms of Parkinson's include tremors, rigidity, bradykinesia slowness of movement, and postural instability. As the disease progresses, individuals may also experience cognitive decline, sleep disturbances, and mood disorders. While there is no cure, treatment options include medications such as levodopa, which helps replenish dopamine levels, and Deep Brain Stimulation (DBS) in more advanced cases [5].

Multiple sclerosis is an autoimmune disease that affects the central nervous system (CNS), leading to the destruction of the myelin sheath that insulates nerve fibers. This damage impedes communication between the brain and the rest of the body. MS is often characterized by flare-ups (relapses) followed by periods of remission. Symptoms vary greatly depending on the affected areas of the CNS but may include numbness, weakness, vision problems, balance issues, and difficulty with coordination [6].

The exact cause of MS is unknown, but it is believed to result from a combination of genetic susceptibility and environmental triggers. Disease-Modifying Therapies (DMTs) can help manage the disease, reduce relapses, and slow progression. Epilepsy is a neurological disorder marked by recurrent seizures, which are sudden bursts of electrical activity in the brain. Seizures can manifest in various forms, from brief periods of confusion to severe convulsions. Epilepsy can be caused by a wide range of factors, including genetic predisposition, brain injury, infections, and metabolic disorders. In some cases, no clear cause is identified idiopathic epilepsy [7].

Anti-Epileptic Drugs (AEDs) are the first line of treatment, with surgical options available for individuals whose seizures cannot be controlled with medication. The goal of treatment is to manage and reduce the frequency and severity of seizures. A stroke occurs when blood flow to the brain is interrupted, leading to the death of brain cells due to lack of oxygen. There are two main types of stroke: ischemic caused by a blockage in a blood vessel and hemorrhagic. Symptoms of a stroke can include sudden weakness or numbness on one side of the body, difficulty speaking, vision problems, and loss of coordination. A stroke is a medical emergency, and prompt treatment is crucial to minimize brain damage [8].

Immediate interventions may include clot-busting drugs for ischemic strokes or surgery for hemorrhagic strokes. Rehabilitation following a stroke often involves physical, occupational, and speech therapy to recover lost functions. Migraine is a chronic neurological condition characterized by severe, recurrent headaches, often accompanied by symptoms like nausea, vomiting, and sensitivity to light and sound. The exact cause of migraines is not fully understood, but they are believed to involve changes in brain chemistry, genetics, and environmental factors. Migraines are often triggered by specific factors such as stress, hormonal changes, certain foods, and sleep disturbances [9].

Treatment options include acute medications to relieve pain and preventive treatments to reduce the frequency and severity of attacks. Lifestyle changes, including stress management and dietary adjustments, can also help mitigate migraine episodes. Amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that affects motor neurons in the brain and spinal cord. As the motor neurons die, individuals lose the ability to control voluntary muscles, leading to weakness, difficulty speaking and swallowing, and eventual paralysis. ALS does not typically affect cognitive function, but it can severely impact a person’s quality of life. The exact cause of ALS is largely unknown, but a small percentage of cases are inherited. While there is no cure, treatment focuses on symptom management, and medications such as riluzole can slow disease progression. Guillain-Barré syndrome is a rare autoimmune disorder where the body’s immune system attacks the peripheral nervous system, often following an infection (such as a viral or bacterial infection). GBS typically begins with weakness or tingling in the legs and can progress to muscle paralysis. While many individuals recover from GBS, some experience long-term effects, such as residual weakness or numbness. Treatment involves immunotherapy, such as intravenous immunoglobulin (IVIG) or plasmapheresis, to help manage symptoms and accelerate recovery [10].

Conclusion

Neurological disorders encompass a diverse array of conditions that can affect the nervous system, leading to a wide range of physical and cognitive impairments. Whether caused by degenerative diseases, trauma, infections, or autoimmune responses, these disorders present significant challenges not only for those affected but also for their families and caregivers. Advances in medical research and treatment options have improved the management of many neurological conditions, offering hope for individuals living with these disorders. However, there is still much to learn about the underlying causes of many neurological diseases. Early diagnosis, intervention, and supportive therapies remain critical for improving outcomes and enhancing quality of life for individuals with neurological disorders.

References

  1. Chase J. Caring for Frail Older Adults during COVID?19: Integrating public health ethics into clinical practice. J  Am Geriatr Soc. 2020;68(8):1666-70.

    2. Indexed at, Google Scholar, Crossref

  2. Coppo A, Bellani G, Winterton D, et al Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): A prospective cohort study.The Lancet Respir Med. 2020;8(8):765-74.

    3. Indexed at, Google Scholar, Crossref

  3. Picard C, Douma MJ. Commentary on Prone Positioning of Patients With Coronavirus Disease 2019 Who Are Nonintubated in Hypoxic Respiratory Distress. J Emerg Nurs. 2021;47(2):214-7.

    4. Indexed at, Google Scholar, Crossref

  4. Elpern E, Killeen K, Patel G, et al. The application of intermittent pneumatic compression devices for thromboprophylaxis. AJN  Am J Nurs. 2013;113(4):30-6.

    5. Indexed at, Google Scholar, Crossref

  5. Labropoulos N, Cunningham J, Kang SS, et al. Optimising the performance of intermittent pneumatic compression devices. Eur J Vascular and Endovascular Surg. 2000;19(6):593-7.

    6. Indexed at, Google Scholar, Crossref

  6. Chouhan VD, Comerota AJ, Sun L, et al. Inhibition of tissue factor pathway during intermittent pneumatic compression: a possible mechanism for antithrombotic effect. Arteriosclerosis, Thrombosis, and Vascular Biol. 1999;19(11):2812-7.

    7. Indexed at, Google Scholar, Crossref

  7. Pollock AS, Legg L, Langhorne P, et al. Barriers to achieving evidence-based stroke rehabilitation. Clin Rehabili. 2000;14(6):611-7.

    8. Indexed at, Google Scholar, Crossref

  8. Lennon S. Using standardised scales to document outcome in stroke rehabilitation. Physiother. 1995;81(4):200-2.

    9. Google Scholar, Crossref

  9. Davidson I, Waters K. Physiotherapists working with stroke patients: A national survey. Physiother. 2000;86(2):69-80.

    10. Google Scholar, Crossref

  10. Van Wijck FM, Pandyan AD, Johnson GR, et al. Assessing motor deficits in neurological rehabilitation: patterns of instrument usage. Neurorehabili Neural Repair. 2001;15(1):23-30.

    11. Indexed at, Google Scholar, Crossref

Get the App